AIT Bioscience sets a new standard for quantitative bioanalysis
AIT Bioscience provides quantitative bioanalytical support for pre-clinical and Phase I through Phase III clinical trials. We understand the different perspectives of the largest pharmas and the smallest biotechs and have experience working with both. Our goal is to provide you with robust analytical methods, painless sample logistics, and rapid sample analyses that will support your program through to the IND and NDA.
Our capabilities include:
Method development, validation, and state-of-the-art instrumentation
Our scientific team draws from extensive experience in novel extraction strategies to create and validate methods for new molecules using the newest models of instrumentation available.
Robotic approaches replace what many labs still execute manually to reduce error and improve throughput.
Our “greenfield” strategy operates on the latest and greatest instrumentation in the industry, including top-of-the-line triple quadrupole systems coupled to UPLC® front ends for the fastest and most sensitive determinations possible. Click here to learn more about our lab.
Valued relationships
The members of our scientific team serve as your direct points of contact and work to keep you informed throughout the testing process, providing detailed results and interpretation every step of the way. Whether you work for a start-up of five or a company much larger, we value our relationship with each client and take the time to cultivate it.
Close partnership with quality assurance
At AIT Bioscience, quality assurance is considered a respected part of our team, not an adversary. As a result, QA principles are built into every step of every workflow right at the beginning. An advanced electronic notebook management system identifies and addresses potential errors in real time. Click here to learn more about our QA processes.